SAFE MATE I.V. FLUID DELIVERY SETS
Device Facts
| Record ID | K962802 |
|---|---|
| Device Name | SAFE MATE I.V. FLUID DELIVERY SETS |
| Applicant | Biological & Environmental Control Laboratories |
| Product Code | FPA · General Hospital |
| Decision Date | Aug 28, 1996 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 880.5440 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
The B.E.C. Safe Mate I.V. Fluid Delivery Sets consist of a PVC tubing set which has a male luer (slip, fixed luer-lock, or rotating luer-lock) connector or an attached schrouded plastic cannula at one end intended to connect to an I.V. catheter, needle or a split septum injection site extension set affixed to an I.V. catheter. Fluid delivery set lengths may vary from 60" up to 120" or longer. Fluid Delivery Sets may also have one or more split septum Y-sites for the infusion of other liquid medications. Clamps (slide, clip, or roller) may also be included.
Device Story
I.V. fluid delivery set; PVC tubing; male luer connectors or shrouded plastic cannula; split septum Y-sites; slide/clip/roller clamps. Used by healthcare providers in clinical settings for intravascular fluid/medication administration. Replaces sharp needles with 11-gauge blunt plastic cannula for split septum access; reduces needlestick injury risk. Connects to I.V. catheters or extension sets. Passive safety mechanism; no active processing.
Clinical Evidence
Bench testing only. Biocompatibility testing confirms materials meet USP Class VI and/or Tripartite guidelines. Sterilization validated via ethylene oxide process.
Technological Characteristics
PVC tubing; 11-gauge blunt plastic cannula; male luer (slip, fixed, or rotating) connectors; split septum Y-sites; slide/clip/roller clamps. Materials meet USP Class VI and Tripartite biocompatibility standards. Sterilization: Ethylene oxide.
Indications for Use
Indicated for intravascular administration of fluids and medications in patients requiring I.V. therapy. Intended to provide protection against inadvertent needlestick injuries to healthcare providers by enabling needleless access to split septum injection sites or Y-sites using an 11 gauge blunt plastic cannula.
Regulatory Classification
Identification
An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.
Special Controls
*Classification.* Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
Predicate Devices
- Medical Network Associates, Incorporated I.V. Fluid Delivery Sets (K955821)
- IMED Corporations Needleless Devices (K945070)
- IMED Corporations Needleless Devices (K944320)
- IMED Corporations Needleless Devices (K931173)
Related Devices
- K962801 — SAFE MATE I.V. EXTENSION SETS · Biological & Environmental Control Laboratories · Aug 28, 1996
- K991932 — INTRAVASCULAR ADMINISTRATION SET · The Kipp Group · Aug 20, 1999
- K980127 — 6 INCH MINI-BONE EXTENSION SET WITH LUER LOCK, NES01S, 6 INCH MIN-BONE EXTENSION SET WITH LUER SLIP, NES02S, 6 INCH STAT · Catheter Innovations, Inc. · Mar 11, 1998
- K171957 — MaxZero Extension Sets with Needless Connector · Carefusion 303, Inc. · Jul 19, 2017
- K042936 — SOLUTION ADMINISTRATION WITH LUER ACCESS INJECTION SITE · Baxter Healthcare Corp · Nov 26, 2004